Long-acting RNA-Based cholesterol therapies: A new frontier in cardiovascular disease prevention
Long-Acting RNA-Based Cholesterol Therapies Hello, And for today , here is my below new interesting paper called: "Long-Acting RNA-Based Cholesterol Therapies: A New Frontier in Cardiovascular Disease Prevention" , and notice that it is saying in the conclusion the following: "The development of long-acting RNA-based cholesterol therapies represents one of the most important advances in cardiovascular prevention since the introduction of statins. By targeting PCSK9 production at the genetic messenger level, inclisiran provides sustained reductions in LDL cholesterol while requiring only infrequent administration. Clinical trials have demonstrated robust efficacy, favorable safety profiles, and the potential for greatly improved treatment adherence. Although challenges related to cost and implementation persist, and definitive proof regarding long-term cardiovascular outcome reductions (MACE) is currently awaited via the ORION-4 trial, current evidence sug...